We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+18.18%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$4.65B
AUM Growth
+$265M
Cap. Flow
+$90.1M
Cap. Flow %
1.94%
Top 10 Hldgs %
14.76%
Holding
1,541
New
606
Increased
154
Reduced
157
Closed
549

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$22.7M
2
BIIB icon
Biogen
BIIB
+$20.4M
3
NEM icon
Newmont
NEM
+$17.6M
4
CNC icon
Centene
CNC
+$14.6M
5
W icon
Wayfair
W
+$14.5M

Sector Composition

Rank Sector Weight
1 Healthcare 5.25%
2 Consumer Discretionary 3.98%
3 Technology 1.67%
4 Materials 1.07%
5 Industrials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTM icon
951
Verastem
VSTM
$510M
$123K ﹤0.01%
+4,167
New +$117K
VSTM icon
952
PUT
Verastem
VSTM
$510M
$123K ﹤0.01%
+4,167
New +$117K
RDI icon
953
CALL
Reading International Class A
RDI
$33.2M
$120K ﹤0.01%
21,600
SENS icon
954
Senseonics Holdings Inc
SENS
$263M
$115K ﹤0.01%
+2,195
New +$124K
NCMI icon
955
CALL
National CineMedia
NCMI
$376M
$113K ﹤0.01%
2,460
PRTS icon
956
CALL
CarParts.com
PRTS
$43.7M
$102K ﹤0.01%
+710
New +$115K
FIRY
957
Firy Inc
FIRY
$148M
$102K ﹤0.01%
+266
New +$153K
FPRX
958
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$102K ﹤0.01%
+2,700
New +$67.3K
BBW icon
959
Build-A-Bear
BBW
$425M
$99K ﹤0.01%
+14,346
New +$88.2K
KGC icon
960
Kinross Gold
KGC
$27.4B
$98K ﹤0.01%
+14,697
New +$102K
SLDB icon
961
Solid Biosciences
SLDB
$794M
$98K ﹤0.01%
+1,167
New +$129K
CORT icon
962
Corcept Therapeutics
CORT
$12.4B
$95K ﹤0.01%
+4,000
New +$107K
GSM icon
963
FerroAtlántica
GSM
$594M
$95K ﹤0.01%
+25,000
New +$74.3K
AM icon
964
CALL
Antero Midstream
AM
$10.4B
$90K ﹤0.01%
+10,000
New +$86.2K
EGIO
965
PUT
DELISTED
Edgio, Inc. Common Stock
EGIO
$89K ﹤0.01%
625
RIGL icon
966
CALL
Rigel Pharmaceuticals
RIGL
$681M
$86K ﹤0.01%
+2,500
New +$99K
RIGL icon
967
PUT
Rigel Pharmaceuticals
RIGL
$681M
$86K ﹤0.01%
+2,500
New +$99K
OTIC
968
DELISTED
Otonomy, Inc.
OTIC
$85K ﹤0.01%
+33,210
New +$136K
PGEN icon
969
Precigen
PGEN
$2.24B
$82K ﹤0.01%
11,882
-34,837
-75% -$294K
SILV
970
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$80K ﹤0.01%
10,000
-18,000
-64% -$165K
SPRT
971
DELISTED
support.com, Inc.
SPRT
$78K ﹤0.01%
+17,000
New +$43.9K
MCFE
972
DELISTED
McAfee Corp. Class A Common Stock
MCFE
$75K ﹤0.01%
+3,300
New +$68.6K
TEVA icon
973
Teva Pharmaceuticals
TEVA
$40.8B
$69K ﹤0.01%
+6,000
New +$68.8K
MGI
974
DELISTED
MoneyGram International, Inc. New
MGI
$67K ﹤0.01%
+10,155
New +$74.4K
VXRT
975
DELISTED
Vaxart
VXRT
$62K ﹤0.01%
+10,225
New +$78.7K

Similar funds

Caption Management's Q1 2021 Portfolio in Review

As of Q1 2021, Caption Management held 1,541 positions worth $4.65B, up 6% from $4.39B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Caption Management's Q1 2021 filing shows 606 new, 154 increased, 157 reduced and 549 closed positions. Its largest new stake was Amgen: 95,000 shares worth $23.6M. The largest sale was Enphase Energy, an estimated $25.5M.

By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 3.2% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Caption Management's largest Q1 2021 buy was Amgen: 95,000 shares worth $23.6M.
  • Caption Management added most to Wayfair in Q1 2021, an estimated $14.5M increase.
  • Caption Management's biggest Q1 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $19.6M.
  • Caption Management fully exited Enphase Energy in Q1 2021, selling an estimated $25.5M.
  • Caption Management's ten largest holdings make up 15% of its $4.65B portfolio in Q1 2021.
  • Caption Management opened 606 new positions and closed 549 in Q1 2021.
  • Caption Management's portfolio value rose 6% quarter-over-quarter to $4.65B.

Based on Caption Management's 13F filing for Q1 2021, filed 17 May 2021.